Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban vs warfarin for left ventricular thrombosis after acute myocardial infarction
IRCT20220809055645N1Phase 3Completed
- Sponsor
- Guilan University of Medical Sciences
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of apixaban in Left ventricular thrombosis (LVT) and myocardial infarction (MI) (2 arms), sponsored by Guilan University of Medical Sciences. Started Aug 2022; status: completed.
02
Drugs
apixaban
03
Conditions
Left ventricular thrombosis (LVT)myocardial infarction (MI)
Beyond the preview
Go deeper on IRCT20220809055645N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20220809055645N1.